Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001279569-06-000239
Filing Date
2006-03-02
Accepted
2006-03-02 08:36:14
Documents
6
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K aspreva10k.htm 10-K 1867624
2 CONSENT OF ERNST & YOUNG LLP ex231.htm EX-23.1 3869
3 CEO CERTIFICATION ex311.htm EX-31.1 16270
4 CFO CERTIFICATION ex312.htm EX-31.2 12657
5 CEO CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 ex321.htm EX-32.1 8354
6 CFO CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 ex322.htm EX-32.2 8209
  Complete submission text file 0001279569-06-000239.txt   1918388
Mailing Address 1203-4464 MARKHAM STREET VICTORIA A1 V8Z 7X8
Business Address 1203-4464 MARKHAM STREET VICTORIA A1 V8Z 7X8 (250) 744-2488
Aspreva Pharmaceuticals CORP (Filer) CIK: 0001314026 (see all company filings)

EIN.: 980435540 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51169 | Film No.: 06657879
SIC: 2834 Pharmaceutical Preparations